Alteration of Egr-1 mRNA during multistage carcinogenesis in mouse skin

Molecular Carcinogenesis

Volumn 27, Issue 4, 2000, Pages 247-251

  Riggs, Penny K ^a   Rho, Okkyung ^a   DiGiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

DNA binding protein; Gene expression regulation; Transcription factor; Tumor promotion

Indexed keywords

DNA BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMEDIATE EARLY GENE; MITOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOGENESIS; TUMOR PROMOTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; IMMEDIATE-EARLY PROTEINS; MICE; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0034069547     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(200004)27:4<247::AID-MC1>3.0.CO;2-4     Document Type: Article

References (36)

1. Sukhatme VP. Early transcriptional events in cell growth: The Egr family. J Am Soc Nephrol 1990;1:859-866.
2. Gashler A, Sukhatme VP. Early growth response protein 1 (Egr-1): Prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol 1995;50:191-224.
3. Gashler AL, Swaminathan S, Sukhatme VP. A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Molec Cell Biol 1993; 13:4556-4571.
4. Joseph LJ, LeBeau MM, Jamison GA Jr, et al. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc binding finger" structure. Proc Natl Acad Sci USA 1988; 85:7164-7168.
5. Patwardhan S, Gashler A, Siegel MG, et al. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene 1991;6:917-928.
6. Crosby SD, Veile RA, Donis-Keller H, et al. Neural-specific expression, genomic structure, and chromosomal localization of the gene encoding the zinc-finger transcription factor NGF1-C. Proc Natl Acad Sci USA 1992;89: 4739-4743.
7. Little MH, Holmes G, Pell L, et al. A novel target for the Wilms' tumor suppressor protein (WT1) is bound by a unique combination of zinc fingers. Oncogene 1996;13: 1461-1469.
8. Sukhatme VP, Kartha S, Toback FG, Hoover RG, Tsai-Morris CH. A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res 1987;1:343-355.
9. Sukhatme VP, Cao XM, Chang LC, et al. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988; 5337-5343.
10. Harada S, Smith RM, White MF, Jarett L. Insulin-induced egr-1 and c-fos expression in 32D cells requires insulin receptor, Shc, and mitogen-activated protein kinase, but not insulin receptor substrate-1 and phosphatidylinositol 3-kinase activation. J Biol Chem 1996;271:30222-30226.
11. Larson FG, Voorhees JJ, Astrom A. Retinoic acid induces expression of early growth response gene-1 (Egr-1) in human skin in vivo and in cultured skin fibroblasts. J Invest Dermatol 1994;102:730-733.
12. Milbrandt J. A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987; 238:797-799.
13. Kharbanda S, Nakamura T, Stone R, et al. Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. J Clin Invest 1991; 88:571-577.
14. Sells SF, Muthukumar S, Sukhatme VP, Crist SA, Rangekar VM. The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest. Mol Cell Biol 1995;15:682-692.
15. Eid MA, Kumar V, Iczkowski KA, Bostwick DG, Tindall DJ. Expression of early growth response genes in human prostate cancer. Cancer Res 1998;58:2461-2468.
16. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 1995;55: 5054-5062.
17. Liu C, Adamson ED, Mercola D. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc Natl Acad Sci USA 1996;93: 11831-11836.
18. Huang RP, Darland T, Okamura D, Mercola D, Adamson ED. Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 1994;9: 1367-1377.
19. Levin WJ, Press MF, Gaynor RB, et al. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. Oncogene 1995;11:1261-1269.
20. Muthukkumar S, Nair P, Sells SF, Maddiwar NG, Jacob RJ, Rangnekar VM. Role of EGR-1 in thapsigargin-inducible apoptosis in the melanoma cell line A375-C6. Mol Cell Biol 1995;15:6262-6272.
21. Nair P, Muthukkumar S, Sells SF, Man SS, Sukhatme VP, Rangnekar VM. Early growth response-1-dependent apoptosis is mediated by p53. J Biol Chem 1997;272: 20131-20138.
22. DiGiovanni J. Tumor-promoting activity of 1,8-dihdroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice. Abstract. Proceedings of the American Association for Cancer Research 1983;24:60.
23. Xian W, Rosenberg M, DiGiovanni J. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: Possible role in mouse skin tumor promotion. Oncogene 1997;1412: 1435-1444.
24. Franke W, Schmid E, Breitkreutz D, et al. Simultaneous expression of two different types of intermediate sized filaments in mouse keratinocytes proliferating in vitro. Differentiation 1979;14:35-50.
25. Yuspa SH, Morgan DL. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature 1981;293:72-74.
26. Conti CJ, Fries JW, Viaje A, Miller DR, Morris R, Slaga TJ. In vivo behavior of murine epidermal cell lines derived from initiated and noninitiated skin. Cancer Res 1988;48: 435-439.
27. Bonfil RD, Momiki S, Conti CJ, Klein-Szanto AJ. Benzoyl peroxide enhances the invasive ability of a mouse epidermal carcinoma cell line. Int J Cancer 1989;44:155-169.
28. Chomczynski D, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
29. Aurray C, Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1987;107:308-314.
30. Kiguchi K, Beltran LM, You J, Rho O, DiGiovanni J. Elevation of transforming growth factor-α mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol Carcinog 1995;12:225-235.
31. Christy BA, Lau LF, Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc Natl Acad Sci USA 1988;85: 7857-7861.
32. Balmain A, Krumlauf R, Vass JK, Birnie GD. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res 1982;10:4259-4277.
33. You L, Jakowlew SB. Identification of early growth response gene-1 (EGR-1) as a phorbol myristate acetate-induced gene in lung cancer cells by differential mRNA display. Am J Respir Cell Mol Biol 1997;17:617-624.
34. McCoy C, McGee SB, Cornwell MM. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter. Cell Growth Differ 1999;10:377-386.
35. Huang C, Ma W-Y, Dawson MI, Rincon M, Flavell RA, Dong Z. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid. Proc Natl Acad Sci USA 1997;94:5826-5830.
36. Slaga TJ, Klein-Szanto AJ, Fischer SM, Weeks CE, Nelson K, Major S. Studies on mechanism of action of anti-tumor-promoting agents: Their specificity in two-stage promotion. Proc Natl Acad Sci USA 1980;77:2251-2254.